Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A2: The duration varies by individual, but the whitening effect generally lasts about three days
Key published studies include: Teichman et al., 2006 (JCEM): Dose-dependent GH and IGF-1 elevation with CJC-1295 DAC in healthy adults Raun et al., 1998 (Eur J Endocrinol): Ipamorelin demonstrated selective GH release without cortisol/prolactin elevation Johansen et al., 1999: Phase I/II Ipamorelin trial showed dose-response relationship with no significant adverse effects Bowers et al., 2004: Foundational research on GHRH/GHRP synergistic GH release mechanisms Neither CJC-1295 nor Ipamorelin has completed Phase 3 clinical trials
The tirzepatide dose remains the same
Research published in the Journal of Endocrinology demonstrated that while GHRP-6 and GHRP-2 both increased ACTH and cortisol, ipamorelin did not produce ACTH or cortisol levels significantly different from those observed following GHRH stimulation alone
IH: Writing review & editing
10.1097/MOG.0b013e3283505a3b 17
